451 related articles for article (PubMed ID: 27157273)
1. Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
Laroni A; Armentani E; Kerlero de Rosbo N; Ivaldi F; Marcenaro E; Sivori S; Gandhi R; Weiner HL; Moretta A; Mancardi GL; Uccelli A
J Autoimmun; 2016 Aug; 72():8-18. PubMed ID: 27157273
[TBL] [Abstract][Full Text] [Related]
2. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A.
Nielsen N; Ødum N; Ursø B; Lanier LL; Spee P
PLoS One; 2012; 7(2):e31959. PubMed ID: 22384114
[TBL] [Abstract][Full Text] [Related]
4. CD56
Wang H; Zeng Y; Zhang M; Ma H; Xu B; Jiang H; Wang J; Li G
Hum Immunol; 2019 Oct; 80(10):871-877. PubMed ID: 31326139
[TBL] [Abstract][Full Text] [Related]
5. Expressions of natural cytotoxicity receptors and NKG2D on decidual natural killer cells in patients having spontaneous abortions.
Zhang Y; Zhao A; Wang X; Shi G; Jin H; Lin Q
Fertil Steril; 2008 Nov; 90(5):1931-7. PubMed ID: 18023431
[TBL] [Abstract][Full Text] [Related]
6. Tumor infiltrating NK cell (TINK) subsets and functional molecules in patients with breast cancer.
Rezaeifard S; Talei A; Shariat M; Erfani N
Mol Immunol; 2021 Aug; 136():161-167. PubMed ID: 34171565
[TBL] [Abstract][Full Text] [Related]
7. Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells.
Marafini I; Monteleone I; Di Fusco D; Sedda S; Cupi ML; Fina D; Paoluzi AO; Pallone F; Monteleone G
PLoS One; 2016; 11(5):e0155103. PubMed ID: 27171408
[TBL] [Abstract][Full Text] [Related]
8. An IL-2 paradox: blocking CD25 on T cells induces IL-2-driven activation of CD56(bright) NK cells.
Martin JF; Perry JS; Jakhete NR; Wang X; Bielekova B
J Immunol; 2010 Jul; 185(2):1311-20. PubMed ID: 20543101
[TBL] [Abstract][Full Text] [Related]
9. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.
Bielekova B; Catalfamo M; Reichert-Scrivner S; Packer A; Cerna M; Waldmann TA; McFarland H; Henkart PA; Martin R
Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5941-6. PubMed ID: 16585503
[TBL] [Abstract][Full Text] [Related]
10. Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis.
Jiang W; Chai NR; Maric D; Bielekova B
J Immunol; 2011 Jul; 187(2):781-90. PubMed ID: 21666061
[TBL] [Abstract][Full Text] [Related]
11. NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56.
Tarazona R; DelaRosa O; Casado JG; Torre-Cisneros J; Villanueva JL; Galiani MD; Peña J; Solana R
AIDS; 2002 Jan; 16(2):197-200. PubMed ID: 11807303
[TBL] [Abstract][Full Text] [Related]
12. A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.
Vargas-Inchaustegui DA; Demberg T; Robert-Guroff M
Immunology; 2011 Nov; 134(3):326-40. PubMed ID: 21978002
[TBL] [Abstract][Full Text] [Related]
13. An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation.
Dulphy N; Haas P; Busson M; Belhadj S; Peffault de Latour R; Robin M; Carmagnat M; Loiseau P; Tamouza R; Scieux C; Rabian C; Di Santo JP; Charron D; Janin A; Socié G; Toubert A
J Immunol; 2008 Aug; 181(3):2227-37. PubMed ID: 18641363
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry.
Ranganath T; Simpson LJ; Ferreira AM; Seiler C; Vendrame E; Zhao N; Fontenot JD; Holmes S; Blish CA
Front Immunol; 2020; 11():714. PubMed ID: 32391016
[TBL] [Abstract][Full Text] [Related]
15. Low-dose IL-2 induces CD56
McQuaid SL; Loughran ST; Power PA; Maguire P; Szczygiel A; Johnson PA
Clin Exp Immunol; 2020 Jun; 200(3):228-241. PubMed ID: 31989589
[TBL] [Abstract][Full Text] [Related]
16. Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults.
Lutz CT; Karapetyan A; Al-Attar A; Shelton BJ; Holt KJ; Tucker JH; Presnell SR
J Immunol; 2011 Apr; 186(8):4590-8. PubMed ID: 21402893
[TBL] [Abstract][Full Text] [Related]
17. Single-cell profiling reveals periventricular CD56
Rodríguez-Lorenzo S; van Olst L; Rodriguez-Mogeda C; Kamermans A; van der Pol SMA; Rodríguez E; Kooij G; de Vries HE
Elife; 2022 May; 11():. PubMed ID: 35536009
[TBL] [Abstract][Full Text] [Related]
18. NK Cells and Innate-Like T Cells After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
Ruder J; Rex J; Obahor S; Docampo MJ; Müller AMS; Schanz U; Jelcic I; Martin R
Front Immunol; 2021; 12():794077. PubMed ID: 34975899
[TBL] [Abstract][Full Text] [Related]
19. Interferon-γ production by tubulointerstitial human CD56
Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
[TBL] [Abstract][Full Text] [Related]
20. CD56
Jaime P; García-Guerrero N; Estella R; Pardo J; García-Álvarez F; Martinez-Lostao L
Osteoarthritis Cartilage; 2017 Oct; 25(10):1708-1718. PubMed ID: 28668542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]